Single-center experience demonstrates successful desensitization to platinum agents, highlighting gender differences in reactions.
This study demonstrates that desensitization to platinum-based chemotherapy achieved high success rates and produced comparable outcomes across different platinum agents. Notably, HSRs to oxaliplatin were observed significantly more frequently among male patients than HSRs to other platinum agents.
No takes yet. Share an insight, caveat, or question.
Kayıkçı et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: